nelfinavir has been researched along with Low Bone Density in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fakruddin, JM; Laurence, J | 1 |
1 other study(ies) available for nelfinavir and Low Bone Density
| Article | Year |
|---|---|
HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Carrier Proteins; CD3 Complex; Cell Line; Cells, Cultured; Cysteine Endopeptidases; Cytokines; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; HIV Envelope Protein gp120; HIV Protease Inhibitors; Humans; Immunoblotting; Indinavir; Interferon-gamma; Membrane Glycoproteins; Mice; Multienzyme Complexes; Nelfinavir; Osteoclasts; Precipitin Tests; Protease Inhibitors; Proteasome Endopeptidase Complex; Protein Binding; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Ritonavir | 2003 |